Taxetweg, Germany

Catrin Finner

USPTO Granted Patents = 7 

 

Average Co-Inventor Count = 9.9

ph-index = 3

Forward Citations = 11(Granted Patents)


Location History:

  • Taxetweg, DE (2016 - 2018)
  • Neuried, DE (2017 - 2022)
  • Planegg, DE (2020 - 2023)

Company Filing History:


Years Active: 2016-2024

Loading Chart...
Loading Chart...
7 patents (USPTO):Explore Patents

Title: **Innovative Contributions of Catrin Finner in Antibody Drug Conjugates**

Introduction

Catrin Finner, an accomplished inventor based in Taxetweg, Germany, has made significant strides in the field of biomedical research. With a total of seven patents to her name, she has contributed extensively to the development of innovative therapies, particularly in the area of antibody drug conjugates. Her work continues to pave the way for new treatment avenues in cancer therapies, showcasing the critical intersection of science and innovation.

Latest Patents

Among Catrin Finner's notable inventions are two exemplary patents focused on antibody drug conjugates aimed at combating hematopoietic stem cell-related conditions. The first patent outlines a novel approach that provides antibody drug conjugates wherein an antibody or antibody fragment specifically binds to human cKIT. These conjugates are linked to a drug moiety, potentially through a linker. This invention holds promise for pharmaceutical compositions that can ablate hematopoietic stem cells in patients requiring such interventions.

Her second patent highlights anti-cKIT antibodies, antibody fragments, and conjugates, detailing their uses in cancer treatment. This innovative work reflects Finner's dedication to enhancing treatment options and improving patient outcomes through advanced therapeutic methodologies.

Career Highlights

Catrin Finner's career is marked by her commitment to pharmaceutical science, particularly during her tenure at Novartis AG. Her innovative spirit and expertise have allowed her to contribute to significant advancements in her field. Through her research, Finner has demonstrated a remarkable ability to navigate complex scientific challenges and translate her findings into practical solutions that benefit patients.

Collaborations

Throughout her career, Catrin Finner has collaborated with esteemed colleagues, including Siew Ho Schleyer and Tinya Abrams. These partnerships have fostered a rich environment for research and development, enabling the exploration of new ideas and the advancement of innovative therapies in the biotechnology sector. Such collaborations have been vital in enhancing the effectiveness and applicability of her patented inventions.

Conclusion

Catrin Finner's contributions to the realm of antibody drug conjugates underscore the importance of innovation in addressing complex health issues. Her ongoing work at Novartis AG and her successful collaborations further enhance her reputation as a leading inventor in the field. As she continues to develop groundbreaking therapeutics, Finner remains a pivotal figure in the journey towards more effective cancer treatments.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…